Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast Enhanced Super Resolution (CESR) Imaging for Breast, Kidney, and Liver Lesions
NCT07225114Phase 2Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Nov 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial, sponsored by UNC Lineberger Comprehensive Cancer Center. Primary endpoints: Sensitivity of Contrast Enhanced Super-Resolution (CESR) breast imaging at 2 months, Specificity of Contrast Enhanced Super-Resolution (CESR) breast imaging at 2 months and 4 more. Started Nov 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07225114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225114.